Literature DB >> 16580861

High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthetase and lyase deficiency: implications for treatment?

F J van Spronsen1, D J Reijngoud, N M Verhoeven, R J Soorani-Lunsing, C Jakobs, P E Sijens.   

Abstract

Cerebral creatine and guanidinoacetate and blood and urine metabolites were studied in four patients with argininosuccinate synthetase (ASS) or argininosuccinate lyase (ASL) deficiency receiving large doses of arginine. Urine and blood metabolites varied largely. Cerebral guanidinoacetate was increased in all patients, while cerebral creatine was low in ASS and high in ASL deficiency. Because high cerebral guanidinoacetate might be toxic, lowering the arginine supplementation with additional creatine supplementation might be important.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580861     DOI: 10.1016/j.ymgme.2006.02.005

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  5 in total

1.  Creatine metabolism in urea cycle defects.

Authors:  Sara Boenzi; Anna Pastore; Diego Martinelli; Bianca Maria Goffredo; Arianna Boiani; Cristiano Rizzo; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2012-05-30       Impact factor: 4.982

Review 2.  Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond.

Authors:  Ayelet Erez; Sandesh C Sreenath Nagamani; Brendan Lee
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-02-10       Impact factor: 3.908

Review 3.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

4.  Expanding the phenotype in argininosuccinic aciduria: need for new therapies.

Authors:  Julien Baruteau; Elisabeth Jameson; Andrew A Morris; Anupam Chakrapani; Saikat Santra; Suresh Vijay; Huriye Kocadag; Clare E Beesley; Stephanie Grunewald; Elaine Murphy; Maureen Cleary; Helen Mundy; Lara Abulhoul; Alexander Broomfield; Robin Lachmann; Yusof Rahman; Peter H Robinson; Lesley MacPherson; Katharine Foster; W Kling Chong; Deborah A Ridout; Kirsten McKay Bounford; Simon N Waddington; Philippa B Mills; Paul Gissen; James E Davison
Journal:  J Inherit Metab Dis       Date:  2017-03-01       Impact factor: 4.982

5.  Urine creatine metabolite panel as a screening test in neurodevelopmental disorders.

Authors:  Shalini Bahl; Dawn Cordeiro; Lauren MacNeil; Andreas Schulze; Saadet Mercimek-Andrews
Journal:  Orphanet J Rare Dis       Date:  2020-12-02       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.